Evidence map›Paper›PMID 26085786›Full record

ArticleCancer informatics2014

Managing Multi-center Flow Cytometry Data for Immune Monitoring.

Scott White, Karoline Laske, Marij Jp Welters, Nicole Bidmon, Sjoerd H van der Burg, Cedrik M Britten, Jennifer Enzor, Janet Staats, Kent J Weinhold, Cécile Gouttefangeas and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancer informatics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Scott WhiteDepartment of Biostatistics and Bioinformatics, Duke University Medical Center, Durham NC, USA.
Karoline LaskeInstitute for Cell Biology, Department of Immunology, Tübingen, Germany.
Marij Jp WeltersExperimental Cancer Immunology and Therapy, Department of Clinical Oncology (K1-P), Leiden University Medical Center, Leiden, the Netherlands.
Nicole BidmonTranslational Oncology at the University Medical Center of the Johannes-Gutenberg University gGmbH, Mainz, Germany.
Sjoerd H van der BurgExperimental Cancer Immunology and Therapy, Department of Clinical Oncology (K1-P), Leiden University Medical Center, Leiden, the Netherlands.
Cedrik M BrittenTranslational Oncology at the University Medical Center of the Johannes-Gutenberg University gGmbH, Mainz, Germany.
Jennifer EnzorSr. Research Analyst, Flow Cytometry Core Facility, Center for AIDS Research, Duke University Medical Center, Durham, NC, USA.
Janet StaatsScientific/Research Laboratory Manager, Flow Cytometry Core Facility, Center for AIDS Research, Duke University Medical Center, Durham, NC, USA.
Kent J WeinholdJoseph W. and Dorothy W. Beard Professor of Surgery, Chief, Division of Surgical Sciences, Professor of Immunology and Pathology, Director, Duke Center for AIDS Research (CFAR), Duke University Medical Center, Durham, NC, USA.
Cécile GouttefangeasInstitute for Cell Biology, Department of Immunology, Tübingen, Germany.
Cliburn ChanDepartment of Biostatistics and Bioinformatics, Duke University Medical Center, Durham NC, USA.
Duke University · USJohannes Gutenberg University Mainz · DELeiden University Medical Center · NL

Funding

Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
NIAID NIH HHS HHSN272201000045CNIAID NIH HHS P30 AI064518
6 · The paper itself

Abstract

With the recent results of promising cancer vaccines and immunotherapy1-5, immune monitoring has become increasingly relevant for measuring treatment-induced effects on T cells, and an essential tool for shedding light on the mechanisms responsible for a successful treatment. Flow cytometry is the canonical multi-parameter assay for the fine characterization of single cells in solution, and is ubiquitously used in pre-clinical tumor immunology and in cancer immunotherapy trials. Current state-of-the-art polychromatic flow cytometry involves multi-step, multi-reagent assays followed by sample acquisition on sophisticated instruments capable of capturing up to 20 parameters per cell at a rate of tens of thousands of cells per second. Given the complexity of flow cytometry assays, reproducibility is a major concern, especially for multi-center studies. A promising approach for improving reproducibility is the use of automated analysis borrowing from statistics, machine learning and information visualization21-23, as these methods directly address the subjectivity, operator-dependence, labor-intensive and low fidelity of manual analysis. However, it is quite time-consuming to investigate and test new automated analysis techniques on large data sets without some centralized information management system. For large-scale automated analysis to be practical, the presence of consistent and high-quality data linked to the raw FCS files is indispensable. In particular, the use of machine-readable standard vocabularies to characterize channel metadata is essential when constructing analytic pipelines to avoid errors in processing, analysis and interpretation of results. For automation, this high-quality metadata needs to be programmatically accessible, implying the need for a consistent Application Programming Interface (API). In this manuscript, we propose that upfront time spent normalizing flow cytometry data to conform to carefully designed data models enables automated analysis, potentially saving time in the long run. The ReFlow informatics framework was developed to address these data management challenges.

Indexed as

automated analysisdata managementdata provenanceFlow cytometrylaboratory informaticsmetadatareproducible analysisREST API

Identifiers

PMID26085786
PMCPMC4463798
OpenAlexW2155489026

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.